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The main objective of the study was to develop 
orodispersible tablets of Granisetron hydrochloride, a selective 5-
HT3 receptor antagonist (an antivomiting agent) for improving 
patient compliance, especially those of paediatric & geriatric 
categories with difficulties in swallowing. In the wet granulation 
method orodispersible (ORD) tablets were prepared using natural 
super disintegrants  plantago ovate.The prepared batches of 
tablets were evaluated for weight variation, hardness, friability, 
wetting time, in vitro dispersion time, drug content and in vitro 
dissolution studies. The tablet formulation batch F4 was 
considered as the overall best formulation (with an in vitro drug 
release study of 99.11%).Short term stability studies (at 
40±2ºC/75±5% RH) on the best formulation indicated that there 
no significant changes in drug content. From the Fourier 
Transform Infrared (FTIR) spectroscopy study indicated that there 
are no drug excipient interactions. 
 
Key words:  Granisetron hydrochloride, Orodispersible tablets, FTIR 
spectroscopy, in vitro drug release study.  
 
INTRODUCTION 
The advances in novel drug delivery 
systems for designing dosage forms like 
orodispersible tablets (Kuchekar et al., 2010; 
Chang et al., 2000) for convenient to be manu-
factured and administered free side effects, 
offering immediate release and enhance 
bioavailability so as to achieve better patient 
compliance. Oral drug delivery systems 
preferably tablets are most widely used dosage 
forms for being compact offering uniform dose 
and painless delivery. But elderly and pediatric 
patients suffer in dysphasia because of 
physiological changes is associated with those 
groups (Lindgreen and Janzon, 1993; Bhushan 
et al., 2000). Generally dysphasia is observed 
nearly 35% of population and associated with a 
number of conditions like parkinsonism, 
mental disabilities, motion sickness, 
unconsciousness, unavailability of water etc. To 
overcome such problems certain innovative 
drug delivery system (Sahoo et al., 2011; Chein, 
1992.) like mouth dissolving tablets have been 
developed.  
The concept of orodispersible tablets 
emerged from the desire to provide patient 
with conventional mean of taking their 
medication. It can be disintegrated, dissolved or 
suspended by saliva in the mouth resulting in 
easy swallowing can provide significant benefits 
to the pediatric and geriatric populations as well 
as other patients who prefer convenience of 
easily swallow able dosage form. Orodispersible 
tablets disintegrate instantaneously when placed 
on tongue, releasing the drug that dissolves or 
disperses in the saliva. The orally disintegrating 
tablets are also called as orodispersible tablets, 
quick disintegrating tablets, fast disintegrating 
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tablets, porous tablets, rapimelts. The mouth 
dissolving tablets are absorbed from the mouth, 
pharynx and esophagus as saliva passes down 
into the stomach (Sahoo et al., 2013). The 
solution containing active ingredients is 
absorbed through gastrointestinal epithelium to 
reach the target and produce desired effect. In 
these cases the bioavailability of drugs are 
significantly greater than those observed from 
conventional solid dosage forms such as tablets 
and capsules (Wilson et al., 1987).  
Granisetron hydrochloride is a selective 
5-HT3 receptor antagonist which has effect on 
controlling nausea and vomiting. Its main effect 
is to reduce the activity of the vagus nerve 
which is a nerve that activates the vomiting 
centre in medulla oblongata. During 
chemotherapy induced vomiting, mucosal 
enterochromaffin cells release serotonin which 
stimulates 5-HT3 receptors. The stimulation of 
5-HT3 receptors by serotonin causes vagal 
discharge resulting in vomiting. Granisetron 
blocks serotonin stimulation and is more 
effective than ondansetron when used in 
combination with dexamethasone in the 
prevention of acute and delayed vomiting 
caused by high emetogenic chemotherapy. 
Granisetron hydrochloride undergoes hepatic 
first pass metabolism with a bioavailability of 
60% and terminal elimination half life between 
3 to 14h after oral administration (Patil  et al., 
2011). In the present study orodispersible 
tablets of granisetron hydrochloride were 
designed using wet granulation method using 
various excipients and plantago ovate as natural 
super disintegrants with prime objective 
arriving of a cost effective product (Bhaskran  
and Narmada, 2002).  
 
MATERIAL AND METHODS 
Granisetron hydrochloride was received 
as a gift sample from Suzikem Labs Pvt Ltd., 
cherlapally, A.P, Mannitol and Aerosil were 
obtained as gifts from Aurobindo labs Pvt Ltd, 
A.P. sodium  saccharin, magnesium stearate,  
talc, micro crystalline cellulose,and potassium 
dihydrogen-o-phosphate were procured from 
SD fine chem. Ltd Mumbai. Sodium hydroxide, 
sodium lauryl sulphate and methanol were 
procured from Qualigens fine chemicals 
Mumbai. 
 
Drug excipient studies 
The FTIR spctroscopy allows 
identification of functional groups in various 
chemicals as well as incompatibilities between 
the drug and excipients. From the FTIR 
spectroscopy study it can be concluded that the 
major peaks of drug  remains intact and no 
interaction was found between the drug and 
excipients. 
 
Preparation of orodispersible tablets 
Accurately weighed quantities of 
ingredients mentioned in table I were passed 
through sieve no. 12. and plantego ovate  was 
passed through sieve no.20. All the ingredients 
lubricant magnesium stearate and talc (glidant) 
were manually blended homogenous by way of 
geometric dilution. The mixture was moistened 
with aqueous solution and granulated with   
sieve no.20 and placed in hot air oven at            
50ºC for sufficient 3-4h. Then dried         
granules passed through sieve no.12 and 
blended with magnesium stearate and talc.            
The homogenous mixture were placed              
into tablet punching machine (10 station            
rotary tablet machine Clint India) getting            
tablet weight 190mg each using deep concave 
punch.  
 
Evaluation of granules 
Pre  compression parameters  of orodispersible 
tablets 
Angle of repose 
The angle of repose (Aithal et al., 2006.) 
of granules blend was determined by the fixed 
funnel method. The accurately weighed 
quantity of granules was taken in a funnel. The 
height of funnel was adjusted in such a way that 
the tip of the funnel just touched the apex of 
the heap of the granules. The granules are 
allowed to flow through the funnel freely onto 
the surface. The diameter of powder cone was 
measured and angle of repose was calculated 
using the following equation 
 
tanϴ = h/r 
ϴ = tan-1(h/r) 
 
Where ϴ is the angle of repose,h is the 
height of cone in cm and r is the radius of the 
cone base in cm.   
 
Chinmaya Keshari Sahoo  
Volume 27 Issue 1 (2016)  37 
Bulk density (еb) 
Bulk density was determined by pouring 
the granules into a graduated cylinder. The bulk 
volume (Vb) and mass (m) of the granules was 
determined. The bulk density was calculated 
(Sahoo  et al., 2015)by using the following 
formula. 
 
Bulk density  
(еb) = 
Mass of granules(m) 
Bulk volume of granules(Vb) 
 
Tapped density (еt) 
The measuring cylinder containing 
known mass of granules blend was tapped 1000 
times for a fixed time. The minimum volume 
occupied in the cylinder (Vt) and mass of the 
granules (m) was measured. The tapped density 
was measured (Satyanarayana  et al., 2015) by 
using the following formula. 
 
Tapped 
density (еb) = 
Mass of granules(m) 
Tapped volume of granules(Vb) 
 
density (еt)= Mass of granules(m)/Tapped 
volume of granules(Vb) 
 
Compressibility index (Carr’s index) 
The compressibility index (Danagi  et al., 
2006.) [14] determines the flow property 
characteristics of granules developed by Carr. 
The percentage compressibility of granules is a 
direct measure of the potential powder arch 
and stability. The Carr’s index can be calculated 
by the following formula. 
 
%Carr’s index= 




Where et is the tapped density of 
granules and eb is bulk density of granules 
 
Hausner’s ratio 
Hausner’s ratio is used for the 
determination of flow properties of granules 
(Sahoo et al., 2015). The ratio can be calculated 
by the taking the ratio of tapped density to the 
ratio of bulk density. 
 
Post compression parameters  of 
orodispersible tablets 
Thickness 
The thickness of individual tablets is 
measured by using vernier calliper (Sahoo et al., 
2012) which gives the accurate measurement of 
thickness. It provides information of variation 
of thickness between tablets. Generally the  
unit for thickness measurement is mm. The 




The hardness of prepared tablets was 
determined by using Monsanto hardness tester  
(Shishu et al.,  2007) and measured in terms of 
kg/cm2. Test was done in triplicate. 
 
Friability 
Friability (Malke et al., 2007) of tablets 
was performed in a Roche friabilator. Ten 
tablets were initially weighed (W0) together              
and then placed in the chamber. The friabilator 
was operated for 100 revolutions and                     
the tablets were subjected to the combined 
effects of abrasion and shock because                   
the Plastic chamber carrying the tablets drops 
them at a distance of six inches with                 
every revolution. The tablets are then dusted 
and reweighed (W). The percentage of           
friability was calculated using the following 
equation. 
 
%Friability  = F = (1- 
W0 ) ×100 W 
 
Where, W0 and W are the weight of the 
tablets before and after the test respectively. 




The weight variation test [19] was done by 
weighing 20 tablets individually (Shimadzu 
digital balance), calculating the average weight 
and comparing the individual tablet weights to 
the average. The percentage weight deviation 




Six tablets along disc were introduced in 
each tube of basket of disintegration (Jain et al., 
2009) test apparatus (Lab care instruments). 
The basket was positioned into a beaker 
containing 900mL of distilled water and 
operated at 372°C. The time of disintegration 
of tablet was recorded. The average time and 
standard deviation were calculated. Three trails 
were performed. 
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Wetting time 
The Wetting time (Bhardwaj et al., 2010) 
of the tablets can be measured using a simple 
procedure. Five circular tissue papers of 10cm 
diameter are placed in petri dish with a 10cm 
diameter. Wetting time was measured by 
placing a tablet on a piece of tissue paper 
folded twice, and was placed in a small petri 
dish containing 6mL of simulated saliva pH 6.8, 
and the time for complete wetting was 
measured. Five tablets from each batch were 
used.  
 
Water absorption ratio:  
A piece of tissue paper folded twice was 
placed in a small Petri dish (internal diameter = 
6.5cm) containing 5mL of distilled water. A 
tablet was placed on the tissue paper. The 
wetted tablet was weighed. The test was done 
in triplicate. The water absorption (Swamy et al., 
2007) ratio(R) was determined according to the 
following equation, 
 
Water absorption =  




Where, Wa is the weight of the tablets 
before the test and Wb is the weight of the 
tablet after water absorption. 
 
Drug content 
Drug content for ORD tablet was done 
by the assay method (Bi et al., 1999; Bhagwati et 
al., 2005). First the prepared tablet (2mg API) 
was crushed and added to 10mL of phosphate 
buffer pH 6.8. After 30min the solution was 
filtered and from 10mL solution 1mL solution 
was withdrawn diluted upto 20mL with 
phosphate buffer pH 6.8 (10µg/mL). This 
solution concentration for the drug content of 
formulations were calculated using calibrated 
standard curve equation y=0.033x+0.018.The 
drug content was determined at λmax302 nm 
by UV-spectrophotometer (ELICO164) against 
blank. 
 
In vitro dissolution studies 
The release rate of Granisetron 
hydrochloride (Aithal et al., 2006; Desai et al., 
2006). Orodispersible tablets was determined 
using United States pharmacopeia (USP) 
dissolution testing apparatus type 2 (paddle 
method). The dissolution test was performed 
using 900mL of Phosphate buffer pH 6.8, at 
37°±0.5°C and 50rpm. In specified time 
intervals (0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 4.5min) 
an aliquot of  5mL samples of the solution were 
withdrawn from the dissolution apparatus and 
with replacement of fresh  fluid to dissolution 
medium. The samples were filtered through 
filter paper of 0.45µm. Absorbance of these 
solutions were measured at λmax 302nm           
using a UV/Visible Spectrophotometer 
(ELICO164). The drug release was plotted 
against time to determine the release profile of 
various batches. 
 
In vitro dispersion time 
This test is performed to ensure 
disintegration of tablets in the salivary fluid, if it 
is to be used as an orodispersible tablet. In vitro 
dispersion (Chaudhari et al., 2005) time was 
measured by dropping a tablet in a measuring 
cylinder containing 6mL of simulated salivary 
fluid of pH 6.8. Three tablets from each 
formulation were randomly selected and in vitro 
dispersion time was measured. 
 
Stability studies 
Tablets were stored at 40±2ºC/75±5% 
RH for a storage period of 0 days, 30 days, 60 
days and 90 days for short term stability study 
(Patil et al., 2011). The post compression 
parameters of tablets were tested during the 
storage period. The changes of dissolution and 
drug content were compared for stability study. 
 
RESULTS AND DISCUSSION 
Drug excipient studies 
The FTIR spectroscopy allows 
identification of functional groups in various 
chemicals as well as incompatibilities between 
the drug and excipients. From the FTIR 
spectroscopy study it was found that there was 
no interaction between peaks of drug as well as 
other ingredients. So from the study it can be 
concluded that the major peaks of drug remains 
intact and no interaction was found between 
the drug and disintgrants. Hence drug and 
excipients are compatible to each other. 
 
Pre-compression parameters of ORD 
formulations 
All the compressible excipients (Table I) 
with   drug   by   wet  granulation   method was  
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prepared using Plantago Ovate along with 
magnesium stearate and talc. This granules 
were evaluated for pre-compressionparameters 
(Table V) such as bulk density, tapped 
density,angle of repose and Carr’s index.  
The bulk density of pre-compression 
blends was found to be in the range of 0.52 to 
0.68g/mL, tapped density in the range of 0.56 
to 0.74g/mL, the Carr’s index values were in 
the range of 12 to 20%, angle of repose in            
the ranges from 23 to 29 degrees and the 
hausner’s ratio was in the range between 1.07 to 
1.17. 
 
Post-compression parameters of ORD 
formulations 
The post compression parameters such 
as hardness, weight variation, drug content 
uniformity, friability and thickness have  given  
below (Table VI). The other parameters             
such  as wetting time, disintegration time and  
in vitro dispersion time have given below         
(Table VII). 
The hardness of the tablet formulations 
was found to be in the range of 
3.85to3.94kg/cm2. The friability values were 
found to be in the range of 0.49 to 0.57%. The 
weight of all the tablets was found to be 
uniform with low values of standard deviation 
and within the prescribed USP limits. The 
average weight of one tablet was found to be in 
range 189 to 190mg. The percent drug              
content of all the tablets was found to be in  
the range of 99.1 to 99.9% of the expected  
drug content, which was within the acceptable 
limits. 
The disintegration time was in range 17 
to 27s, wetting time was found be in range 14 
Table I.  Composition of granisetron hydrochloride orodispersible tablets containing natural 
superdisintegrants    
 
Ingredients(mg) F1 F 2 F 3 F 4 F 5 F 6 
GSH 2 2 2 2 2 2 
Plantago Ovate 4 6 8 10 12 14 
Micro Crystalline Cellulose 126 124 122 120 118 116 
Mannitol 50 50 50 50 50 50 
Aerosil 2 2 2 2 2 2 
Sodium  Saccharin 2 2 2 2 2 2 
Magnesium Stearate 2 2 2 2 2 2 
Talc 2 2 2 2 2 2 
Total weight(mg) 190 190 190 190 190 190 
    
Where ϴ is the angle of repose,h is the height of cone in cm and r is the radius of the cone base in  cm.   
 
Table II. Relationship between powder flowability and angle of repose 
 
Angle of repose(ϴ) Observation 
<250 Free flowing  granules 
>400 Poorly flowing granules 
 
Table III.  Relationship between powder flowability and % compressibility range 
 
%Compressibility index Flow type 
5-15 Excellent flow(free flowing granules) 
12-16 Good 
18-21 Fair(powdered granules) 
23-28 Poor(very fluidpowders) 
28-35 Poor(fluid cohesive powders) 
35-38 Very poor(fluid cohesive powders) 
>40 Extremely poor(cohesive powders) 
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to 24s, in vitro dispersion time was in range 20 
to 34s and the water absorption ratio was 
between 66.23 to 80.48. The results are shown 
in table VII. 
 
In vitro dispersion time 
This test was performed to ensure 
disintegration of tablets in the salivary fluid, if it 
is to be used as an orodispersible tablet. Among 
all formulations F4 formulation was found to 
be best. The dispersion time was found to be 
20s (Figure 1). 
In vitro drug release study 
In vitro drug release studies were 
performed in pH 6.8 phosphate buffer, on the 
above promising formulation (F4) gives 
maximum amount of drug release comparing to 
other formulations. The percentage of drug 
release of F4 was best giving 99.11% in 3min 
comparing to other batches F1 (93.92%in 
4.5min), F2 (95.43 in 4min), F3 (97.32in 
3.5min), F5 (96.23 in 4.5min) and F6 (95.26 in 
4.5min). The dissolution profiles of the above 
formulations are depicted in figure 2. 
Table IV.  Relationship between powder flowability and Hausner’s ratio 
 
Hausner’s ratio Flow type 
1.2 Free flowing granules 
>1.6 Poorly flowing granules 
 







 (gm/mL) ±S.D 
Angle of repo se 





F1 0.56±0.02 0.66±0.08 23.0±0.03 15.15±0.02 1.17±0.08 
F2 0.68±0.11 0.74±0.09 25.0±0.12 8.1±0.13 1.08±0.12 
F3 0.54±0.13 0.68±0.11 24.0±0.11 20.58±0.01 1.2±0.125 
F4 0.58±0.14 0.66±0.02 26.0±0.13 12.12±0.01 1.13±0.01 
F5 0.52±0.15 0.56±0.02 27.0±0.01 7.1±0.14 1.07±0.09 
F6 0.53±0.11 0.58±0.14 29.0±0.09 8.62±0.11 1.09±0.11 
 














F1 3.9±0.02 0.49±0.11 99.2±0.01 191±0.1 4±0.10 
F2 3.89±0.01 0.52±0.01 99.4±0.02 190±0.1 4±0.11 
F3 3.85±0.02 0.57±0.02 99.3±0.03 190±0.1 4±0.14 
F4 3.94±0.05 0.51±0.10 99.9±0.04 189±0.1 4±0.13 
F5 3.85±0.01 0.52±0.01 99.4±0.02 190±0.1 4±0.10 
F6 3.85±0.02 0.53±0.04 99.1±0.02 189±0.1 4±0.10 
 












F1 27±1.01 34±1.02 24±1.1 68.23±1.3 
F2 24±1.05 30±1.02 20±1.02 71.50±1.8 
F3 22±1.11 26±1.02 17±1.06 78.51±1.2 
F4 17±1.23 20±1.02 14±1.07 80.48±1.6 
F5 19±1.12 27±1.01 22±1.02 72.50±1.8 
F6 24±1.04 30±1.02 19±1.02 66.23±1.3 
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Short-term stability studies 
Short-term stability studies on the above 
promising formulation (at 40±2o/75±5% RH 
for 3 months) have shown no significant 
changes in physical appearance, drug content 
and in vitro dispersion time. Statistical analysis 
(‘t’-test) of drug content data gives ‘t’ value of 
1.91 for F4 formulation which is much less 
compared to the table value of 4.3 (p<0.05). 
There are no appreciable changes in in vitro 
dispersion time up on storage at 40±2o/75±5% 
RH for 3 months period.  
 
CONCLUSION 
The study clearly demonstrates that 
orodispersible tablets of granisetron 
hydrochloride  could be successfully prepared 
by wet granulation method in a cost effective 
manner employing plantego ovate. It was 
evident from the results that rate of drug 
release can be optimized using disintegrants for 
orodispersible formulations. From the 
developed formulations the release of 
granisetron hydrochloride was best in F4 
formulation i.e in-vitro study and in vitro 
dispersion time study. From the FTIR 
spectroscopy study, it was confirmed that the 
drug and excipients in the formulations were   
compatible with each other. Hence the 
availability of various technologies and the 
manifold advantages of orodispersible tablets 
will surely enhance the patient compliance 








Figure 2. Comparative in vitro drug release study of GSH batches. 
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